Cytek Biosciences (CTKB) Non-Current Assets (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Non-Current Assets came in at $69.8 million in Q1 2026, down 31.62% YoY from $102.1 million in Q1 2025, and little changed on a QoQ basis from $69.5 million in Q4 2025.
Cytek Biosciences (CTKB) Non-Current Assets (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of Non-Current Assets data on file, last reported at $69.8 million in Q1 2026.
- Quarterly Non-Current Assets fell 31.62% year-over-year to $69.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $356.3 million (down 12.21% YoY) and the FY2025 annual result came in at $69.5 million, down 32.51% from the prior year.
- Non-Current Assets steadied at $69.8 million in Q1 2026, from $69.5 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $110.5 million in Q2 2025 to a low of $46.8 million in Q1 2022.
- A 5-year average of $87.1 million and a median of $99.6 million in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets surged 282.48% — and 2025, when it slumped 32.51%.
- Tracing CTKB's Non-Current Assets over 5 years: stood at $65.5 million in 2022, then soared by 56.44% to $102.4 million in 2023, then rose by 0.64% to $103.1 million in 2024, then tumbled by 32.51% to $69.5 million in 2025, then increased by 0.38% to $69.8 million in 2026.
- The last three Non-Current Assets figures came in at $69.8 million (Q1 2026), $69.5 million (Q4 2025), and $106.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Cytek Biosciences | 602.64 Mn | 528.79 Mn | 28.34 Mn | 69.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 69.00 Mn |
| Mar 31, 2026 | 69.81 Mn |
| Dec 31, 2025 | 69.55 Mn |
| Sep 30, 2025 | 106.43 Mn |
| Jun 30, 2025 | 110.50 Mn |
| Mar 31, 2025 | 102.10 Mn |
| Dec 31, 2024 | 103.05 Mn |
| Sep 30, 2024 | 101.04 Mn |
| Jun 30, 2024 | 99.64 Mn |
| Mar 31, 2024 | 103.42 Mn |
| Dec 31, 2023 | 102.40 Mn |
| Sep 30, 2023 | 97.12 Mn |
| Jun 30, 2023 | 100.23 Mn |
| Mar 31, 2023 | 98.95 Mn |
| Dec 31, 2022 | 65.46 Mn |
| Sep 30, 2022 | 55.44 Mn |
| Jun 30, 2022 | 49.55 Mn |
| Mar 31, 2022 | 46.77 Mn |
| Dec 31, 2021 | 31.57 Mn |
| Sep 30, 2021 | 14.49 Mn |